Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Dumont FJ et al. |
A tacrolimus-related immunosuppressant with reduced toxicity. |
1998 |
Transplantation |
pmid:9448138
|
Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Rosen HR et al. |
Significance of early aminotransferase elevation after liver transplantation. |
1998 |
Transplantation |
pmid:9448146
|
Mieles L et al. |
Interaction between FK506 and clotrimazole in a liver transplant recipient. |
1991 |
Transplantation |
pmid:1721250
|
Roth D et al. |
A prospective study of hepatitis C virus infection in renal allograft recipients. |
1996 |
Transplantation |
pmid:8623154
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Shin BH et al. |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. |
2014 |
Transplantation |
pmid:24342979
|
Yoon SH et al. |
CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). |
2013 |
Transplantation |
pmid:23364483
|
Pirsch JD |
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. |
1999 |
Transplantation |
pmid:10551653
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Lee D et al. |
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. |
2017 |
Transplantation |
pmid:27779572
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Shihab FS et al. |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. |
2009 |
Transplantation |
pmid:19202436
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Takahara S et al. |
The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. |
1992 |
Transplantation |
pmid:1373537
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Cosio FG et al. |
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. |
2007 |
Transplantation |
pmid:17318073
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Timmermann W et al. |
Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. |
1999 |
Transplantation |
pmid:10401762
|
Fujimura Y and Owen RL |
Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches. |
2002 |
Transplantation |
pmid:11965030
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Ciancio G et al. |
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. |
2002 |
Transplantation |
pmid:11965039
|
Castells L et al. |
Liver transplantation in HIV-HCV coinfected patients: a case-control study. |
2007 |
Transplantation |
pmid:17297413
|
Nicolai S and Bunyavanich S |
Hypersensitivity reaction to intravenous but not oral tacrolimus. |
2012 |
Transplantation |
pmid:23128975
|
Kaufman DB et al. |
Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. |
1999 |
Transplantation |
pmid:10071032
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Johansson A and Möller E |
Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical. |
1990 |
Transplantation |
pmid:1701570
|
Reyes J et al. |
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. |
1990 |
Transplantation |
pmid:1701571
|
Bozorgzadeh A et al. |
Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. |
2004 |
Transplantation |
pmid:15087773
|
Benigni A et al. |
The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. |
1992 |
Transplantation |
pmid:1279848
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
Diem HV et al. |
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. |
2003 |
Transplantation |
pmid:12777858
|
Butani L et al. |
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. |
2003 |
Transplantation |
pmid:12883183
|
Luan FL et al. |
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. |
2002 |
Transplantation |
pmid:12042641
|
Smets F et al. |
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. |
2002 |
Transplantation |
pmid:12042647
|
van Rijen MM et al. |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. |
2002 |
Transplantation |
pmid:12042657
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Andoh TF et al. |
Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. |
1994 |
Transplantation |
pmid:7509514
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Imado T et al. |
Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect. |
2004 |
Transplantation |
pmid:14966413
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Boillot O et al. |
Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study. |
1998 |
Transplantation |
pmid:9825815
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Herlenius G et al. |
Chronic kidney disease--a common and serious complication after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622286
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
Akst LM et al. |
Induction of tolerance in a rat model of laryngeal transplantation. |
2003 |
Transplantation |
pmid:14688529
|
Mañez R et al. |
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. |
1995 |
Transplantation |
pmid:7537400
|
Pacifico L et al. |
Tacrolimus and food allergy. |
2003 |
Transplantation |
pmid:14688538
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Richards KR et al. |
Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. |
2014 |
Transplantation |
pmid:24784360
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Ji E et al. |
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
2012 |
Transplantation |
pmid:22992768
|
Hanto DW and Chudzinski R |
What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? |
2009 |
Transplantation |
pmid:19155968
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Morales JM et al. |
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus. |
2008 |
Transplantation |
pmid:18724234
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplantation |
pmid:12499885
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Mikhalski D et al. |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. |
2008 |
Transplantation |
pmid:18401260
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Aw MM et al. |
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. |
2003 |
Transplantation |
pmid:12660504
|
Egli A et al. |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. |
2013 |
Transplantation |
pmid:23274966
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Paolillo JA et al. |
Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11213069
|
Molmenti EP et al. |
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. |
2001 |
Transplantation |
pmid:11213072
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Ueki S et al. |
Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. |
2006 |
Transplantation |
pmid:17198266
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Vincenti F et al. |
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8669100
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Letavernier E et al. |
Proteinuria following a switch from calcineurin inhibitors to sirolimus. |
2005 |
Transplantation |
pmid:16314786
|
Baggio B et al. |
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. |
2005 |
Transplantation |
pmid:16314806
|
Wai LE et al. |
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. |
2008 |
Transplantation |
pmid:18192925
|
Bolley R et al. |
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. |
2002 |
Transplantation |
pmid:11923712
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|